Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

New Taiho, Cullian data heats up lung cancer drug battle

The findings position their drug, zipalertinib, as a threat to multiple approved medicines — while setting a bar for others in testing.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at biopharmadive.com →

More in Health & Medicine

Thursday assorted links

1. Write a paper in six days with only AIs, then record all of that and write a second paper about writing the first. 2. Saloni on the future of medicine. “Every disease is a policy failure.” 3.

More from Thursday 13 August →